MicrobiologyFrontiers in MicrobiologyPeer-reviewed
Author
Julian Gregston Hurdle
Texas A&M Health Science CenterORCID 0000-0003-2214-8105Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2024-2026 · peak 1/yrCo-Author Collaboration Network
10 top collaborators · 24 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship2 papers
Recent·Most cited
- MicrobiologyAntimicrobial Agents and ChemotherapyPeer-reviewed
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) Inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy
Chetna Dureja, Jacob T. Rutherford, Fahad Bin Aziz Pavel…·Julian Gregston Hurdle
This study evaluates the in vivo efficacy of phenylimidazole 296 against C. difficile by targeting CdFabK, showing it retains microbiome stability better than vancomycin and fidaxomicin.
5 citations